Maria-Luisa Maccecchini - Dec 6, 2021 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Jeffrey McGroarty, Attorney-in-Fact for Maria L. Maccecchini
Stock symbol
ANVS
Transactions as of
Dec 6, 2021
Transactions value $
$0
Form type
4
Date filed
12/8/2021, 04:00 PM
Previous filing
Oct 13, 2021
Next filing
Jan 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +113K $0.00 113K Dec 6, 2021 Common Stock 113K $20.97 Direct F1
transaction ANVS Stock Option (right to buy) Award $0 +145K $0.00 145K Dec 6, 2021 Common Stock 145K $20.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is 100% vested.
F2 The stock option shall vest in two installments: (i) the first installment of 72,653 shares on March 31, 2022 and (ii) a second and final installment of 72,652 shares on March 31, 2023, provided that the reporting person continues to be employed by the issuer on the applicable vesting date.